Korro Bio KRRO
NASDAQ KRRO
$13.06 +0.13 (+1.01%)
As of: Sep 10, 2026 · 3:59 PM EDT

Korro Bio (KRRO) Total Debt (2018 - 2023)

Korro Bio's (KRRO) quarterly Total Debt came in at $11.7 million in Q1 2023, down 22.22% on a YoY basis from $15.0 million in Q1 2022, and down 17.65% quarter-over-quarter from $14.2 million in Q4 2022.

Analysis

Korro Bio (KRRO) Total Debt (2018 - 2023) Analysis & Trends

Korro Bio (KRRO) has reported Total Debt for 6 consecutive years, with $11.7 million the latest figure, recorded in Q1 2023.

  • For the quarter ending Q1 2023, Total Debt fell 22.22% year-over-year to $11.7 million; the trailing twelve-month figure through Mar 2023 stood at $11.7 million (down 22.22% YoY), and the FY2022 full-year result was $14.2 million, down 5.55% from the prior year.
  • Total Debt slipped to $11.7 million in Q1 2023 per KRRO's latest filing, from $14.2 million in the prior quarter.
  • Across five years, Total Debt topped out at $15.0 million in Q4 2020 and bottomed at $180000.0 in Q4 2019.
  • Historically, Total Debt has averaged $12.2 million across 5 years, with a median of $15.0 million in 2020.
  • The sharpest annual moves came in 2019 and 2020: Total Debt sank 48.42% in 2019, then surged 8233.33% in 2020.
  • Over 5 years, Total Debt stood at $180000.0 in 2019, then soared by 8233.33% to $15.0 million in 2020, then changed by 0.0% to $15.0 million in 2021, then slipped by 5.55% to $14.2 million in 2022, then fell by 17.65% to $11.7 million in 2023.
  • According to Business Quant data, Total Debt over the past three periods registered $11.7 million, $14.2 million, and $15.0 million for Q1 2023, Q4 2022, and Q3 2022 respectively.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Total Debt (Qtr)
1 Amgen 206.44 Bn 192.45 Bn 7.24 Bn 62.75 Bn
2 Gilead Sciences 179.97 Bn 176.79 Bn 6.22 Bn 28.66 Bn
3 Vertex Pharmaceuticals 130.57 Bn 122.72 Bn 2.84 Bn -
4 Regeneron Pharmaceuticals 81.63 Bn 73.63 Bn 3.93 Bn 1.99 Bn
5 Argenx Se 60.34 Bn 55.16 Bn 1.37 Bn -
6 Moderna 54.37 Bn 49.23 Bn 52.00 Mn 591.00 Mn
7 Alnylam Pharmaceuticals 33.07 Bn 29.76 Bn 992.69 Mn -
8 Biogen 31.84 Bn 30.55 Bn 1.96 Bn 8.09 Bn
9 Roivant Sciences 29.49 Bn 29.49 Bn 1.16 Mn -
10 Korro Bio 231.15 Mn 116.12 Mn - -
Historic Data

Historic Data

Download Data
DateValue
Mar 31, 2023 11.67 Mn
Dec 31, 2022 14.17 Mn
Sep 30, 2022 15.00 Mn
Jun 30, 2022 15.00 Mn
Mar 31, 2022 15.00 Mn
Dec 31, 2021 15.00 Mn
Sep 30, 2021 15.00 Mn
Jun 30, 2021 15.00 Mn
Mar 31, 2021 15.00 Mn
Dec 31, 2020 15.00 Mn
Dec 31, 2019 180,000.00
Sep 30, 2019 222,000.00
Dec 31, 2018 349,000.00